Literature DB >> 16272470

Antigenic divergence of Bordetella pertussis isolates in Taiwan.

Shu-Man Yao1, Yu-Chi Lin, Chen-Ying Chou, Ying-Yan Chen, Miao-Ju Hsiao, Hour-Young Chen, Jer-Jea Yan, Hsun-Pi Su, Shu-Ying Li.   

Abstract

In recent studies, antigenic divergence has been observed in Bordetella pertussis circulating isolates. We collected 80 Bordetella pertussis isolates in Taiwan from 1998 to 2004 and analyzed them using a combination of pulsed-field gel electrophoresis (PFGE) and sequencing of the ptxS1 and prn genes. The incidence of pertussis increases every 3 years, and most of the isolates prevalent since 1998 have expressed nonvaccine ptxS1A and prn2 alleles. Through PFGE analysis, all isolates could be classified into four major groups, and the incidence of these groups exhibited a correlation with the prn allele expressed by the isolates. We found that PFGE is more discriminative than gene sequencing, since it could divide the isolates expressing the prn2 allele into two groups: one group circulating from 1998 to 2001 and another group circulating from 2001 to 2004. The transition between the two groups in 2000 coincided with an outbreak of 326 cases. This research indicates that the antigenic divergence of B. pertussis circulating isolates has evolved over time in Taiwan. Such information will have implications for vaccine policy in Taiwan.

Entities:  

Mesh:

Year:  2005        PMID: 16272470      PMCID: PMC1287815          DOI: 10.1128/JCM.43.11.5457-5461.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population.

Authors:  I H van Loo; H G van der Heide; N J Nagelkerke; J Verhoef; F R Mooi
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

2.  Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland.

Authors:  F R Mooi; Q He; H van Oirschot; J Mertsola
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

3.  Strain variation among Bordetella pertussis isolates from Québec and Alberta provinces of Canada from 1985 to 1994.

Authors:  Mark S Peppler; Sharee Kuny; Anna Nevesinjac; Christina Rogers; Yvon R de Moissac; Kathleen Knowles; Manon Lorange; Gaston De Serres; James Talbot
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

4.  Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles.

Authors:  Abdolreza Advani; Declan Donnelly; Hans Hallander
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

5.  Temporal trends in circulating Bordetella pertussis strains in Australia.

Authors:  M Poynten; P B McIntyre; F R Mooi; K J Heuvelman; G L Gilbert
Journal:  Epidemiol Infect       Date:  2004-04       Impact factor: 2.451

6.  Species identification of medically important fungi by use of real-time LightCycler PCR.

Authors:  Min-Chih Hsu; Kuo-Wei Chen; Hsiu-Jung Lo; Yee-Chun Chen; Mei-Hui Liao; Yu-Hui Lin; Shu-Ying Li
Journal:  J Med Microbiol       Date:  2003-12       Impact factor: 2.472

7.  Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan.

Authors:  Atsuko Kodama; Kazunari Kamachi; Yoshinobu Horiuchi; Toshifumi Konda; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

Review 8.  Pertussis vaccine: present status and future prospects.

Authors:  A Robinson; L I Irons; L A Ashworth
Journal:  Vaccine       Date:  1985-03       Impact factor: 3.641

9.  Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution.

Authors:  F R Mooi; H van Oirschot; K Heuvelman; H G van der Heide; W Gaastra; R J Willems
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

10.  Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine.

Authors:  H E de Melker; M A Conyn-van Spaendonck; H C Rümke; J K van Wijngaarden; F R Mooi; J F Schellekens
Journal:  Emerg Infect Dis       Date:  1997 Apr-Jun       Impact factor: 6.883

View more
  6 in total

1.  Application of a microsphere-based array for rapid identification of Acinetobacter spp. with distinct antimicrobial susceptibilities.

Authors:  Yu-Chi Lin; Wang-Huei Sheng; Shan-Chwen Chang; Jann-Tay Wang; Yee-Chun Chen; Ruei-Jiuan Wu; Ko-Chiang Hsia; Shu-Ying Li
Journal:  J Clin Microbiol       Date:  2007-11-26       Impact factor: 5.948

2.  Studies on Prn variation in the mouse model and comparison with epidemiological data.

Authors:  Marjolein van Gent; Inge H M van Loo; Kees J Heuvelman; Albert J de Neeling; Peter Teunis; Frits R Mooi
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

3.  SNP-based typing: a useful tool to study Bordetella pertussis populations.

Authors:  Marjolein van Gent; Marieke J Bart; Han G J van der Heide; Kees J Heuvelman; Teemu Kallonen; Qiushui He; Jussi Mertsola; Abdolreza Advani; Hans O Hallander; Koen Janssens; Peter W Hermans; Frits R Mooi
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

4.  Multilocus Sequence Analysis of Housekeeping Genes and Antigenic Determinant Genes in Bordetella pertussis Strains Isolated in Korea.

Authors:  Sang-Oun Jung; Yu Mi Moon; So-Hyeon Kim; Hwa Young Sung; Seung-Jik Kwon; Yeon Ho Kang; Jae Yon Yu
Journal:  Osong Public Health Res Perspect       Date:  2011-08-04

Review 5.  Pertussis. A reemerging and an underreported infectious disease.

Authors:  Muhammad A Syed; Noureen F Bana
Journal:  Saudi Med J       Date:  2014-10       Impact factor: 1.484

6.  Comparative genomics of whole-cell pertussis vaccine strains from India.

Authors:  Shweta Alai; Vikas C Ghattargi; Manish Gautam; Krunal Patel; Shrikant P Pawar; Dhiraj P Dhotre; Umesh Shaligram; Sunil Gairola
Journal:  BMC Genomics       Date:  2020-05-07       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.